Aging Research and Drug Discovery

Name

Aging Research and Drug Discovery

Legal name

Insilico Medicine

Website

https://agingpharma.org

Company type

Private

Founded year

2014

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

Product category

Scientific Conference Services

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714), Scientific Research and Development Services (5417)

akta.pro primary industry

AI/ML Platforms for Drug Discovery & Experiment Optimization (HLAGAJAO)

Keywords

• Aging research conference
• Longevity science events
• Drug discovery symposium
• Biogerontology meetings
• Pharma industry forums

Headquarters

HQ city

Copenhagen

HQ country

Denmark

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Operations, Personnel, Marketing or Sales, Infrastructure, Technology or R&D

Revenue model

1. Conference Registration: Revenue from ticket sales for annual ARDD conference events. Registration tiers include Academic ($750) and Non-Academic ($1200) categories. Ticket sales partially cover event costs but do not cover all expenses even at full capacity.
2. Corporate Sponsorship: Major revenue stream through multi-tiered sponsorship packages. Sponsors include pharmaceutical companies (Eli Lilly, AbbVie), biotech firms (Insilico Medicine, BioAge Labs, Human Longevity), and other longevity companies. Sponsorship tiers range from Tier 1 to Tier 5 with varying benefits including speaking slots, exhibition space, and brand visibility.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

ARDD (Aging Research and Drug Discovery) is a non-profit annual international conference series focused on aging biology, geroscience, and drug discovery for age-associated diseases. It convenes academic researchers, pharmaceutical and biotech executives, clinicians, and investors through a multi-day in-person event complemented by online streaming, supplemented by specialized tracks (Longevity Medicine, AI in Drug Discovery, Physics in Aging Biology, Replacement in Aging, Molecular Nutrition), workshops, a startup pitch platform, and educational programs.

Product overview

ARDD (Aging Research and Drug Discovery) is a conference/event series organized by Insilico Medicine that hosts an annual international meeting focused on aging research and longevity science. The core offering is the main ARDD Conference, supplemented by specialized tracks and workshops including the Longevity Medicine Track for clinical applications, the Emerging Science & Technologies Workshop for AI and biotechnology innovations, the Physics in Aging Biology Workshop for theoretical approaches, the Replacement in Aging Workshop for regenerative medicine, the Molecular Nutrition Workshop for nutritional interventions, the Startup Pitch event for entrepreneurial presentations, and the XPRIZE Healthspan Team Summit. Additional offerings include the Inspire Longevity Student Ambassador Program and CME-accredited Longevity Medicine Course for Physicians. The conference also offers video archives of past presentations and various sponsorship tiers for industry participants.

Differentiator

Problem solved

Functional benefit

Brands

• Longevity Medicine Track: Track focused on clinical longevity medicine practice for healthcare providers
• Emerging Science & Technologies Workshop
• Physics in Aging Biology Workshop
• Replacement in Aging Workshop
• Molecular Nutrition Workshop
• Startup Pitch
• Inspire Longevity

Products and services

• ARDD Conference Series Multi-day annual international meeting convening 100+ speakers and 1,000+ onsite attendees (10,000+ online viewers) covering molecular, cellular, and organismal basis of aging and interventions for age-associated diseases. Targeted at academic researchers, pharma/biotech executives, clinicians, and investors in the longevity sector.
• Longevity Medicine Track Track focused on longevity medicine as a clinical discipline, covering precision diagnostics, targeted therapies, and clinical translation of geroscience for physicians and healthcare providers.
• Physics in Aging Biology Workshop Workshop exploring theoretical physics approaches to aging biology, including statistical mechanics, network theory, and nonlinear dynamics applications, for researchers in interdisciplinary aging science.
• Emerging Science & Technologies Workshop Workshop covering AI-powered foundation models, synthetic biology, cell simulations, and biohacking approaches for aging research, targeted at researchers and technologists.
• Replacement in Aging Workshop Workshop exploring replacement-based strategies for restoring function in aged organisms through stem cell biology, regenerative medicine, and organ engineering.
• Molecular Nutrition Workshop Workshop focused on nutrition research and molecular mechanisms for healthy longevity, covering diet, metabolism, and geroprotective nutritional interventions.
• Startup Pitch Pitch platform for longevity-focused startups to present to investors and industry leaders, including jury evaluation and prize sponsorship tiers, facilitating deal flow in the longevity sector.
• XPRIZE Healthspan Team Summit

Quantifiable outcome

• 1,000+ onsite attendees and 10,000+ online viewers for ARDD 2025
• +2 more outcomes

Named customers5 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Seven partnerships are on record, tiered core, minor and supporting.

• McKinsey Health InstitutecoreStrategic or Co-development Partner · 1 January 2026McKinsey Health Institute is the Sole Knowledge Partner for ARDD 2026. This collaboration advances evidence-based dialogue on healthy longevity and supports engagement of pharmaceutical and consumer innovation stakeholders.
• Insilico MedicinecoreStrategic or Co-development Partner · 1 January 2026Insilico Medicine is the Organizer of ARDD 2026. CEO Alex Zhavoronkov serves as Co-Chair of ARDD and Longevity Medicine Co-Chair. The company has been involved with ARDD since 2014.
• ICFSR (Intrinsic Capacity, Frailty & Sarcopenia Research Conference)minorStrategic or Co-development Partner · 1 January 2025Tier 5 Sponsor of ARDD 2026. Related longevity research organization.
• Longevity Education HubsupportingStrategic or Co-development Partner · 1 January 2025Supporting Organization for ARDD 2026. Provides educational resources for longevity science.
• Nordic Aging SocietysupportingStrategic or Co-development Partner · 1 January 2025Supporting Organization for ARDD 2026. Regional aging research society.
• Healthy Longevity Medicine SocietysupportingStrategic or Co-development Partner · 1 January 2025Supporting Organization for ARDD 2026. Professional society for longevity medicine.
• Boston BioLifesupportingStrategic or Co-development Partner · 1 January 2025Supporting Organization for ARDD 2026.

Scale indicators4 records

Recent moves7 records

Expansion highlights5 records

Direct peers

• Gordon Research Conferences: Premier scientific conference organizer running decades-long series of small, invite-driven conferences across the life sciences. Comparable in mission, format, and audience mix of academics, clinicians, and industry participants.
• FASEB Science Research Conferences: Federation of American Societies for Experimental Biology runs scientific research conferences across biomedical disciplines. Comparable as a non-profit scientific conference series targeting academic researchers with industry sponsorship.
• Rejuvenation Startup Summit: Annual longevity-focused summit combining scientific programming with startup pitches and investor networking. Comparable in audience mix (researchers, biotechs, investors) and longevity subject matter.
• Cell Symposia: Publisher-affiliated scientific conference series covering molecular and cell biology, including aging and metabolism. Comparable as a high-profile, branded conference organizer serving academic-industry crossover audiences.
• Keystone Symposia: Long-running organizer of high-quality scientific conferences across molecular biology and biomedical research, including aging-related topics. Directly comparable as a non-profit scientific conference series targeting academic researchers and industry sponsors.
• Cold Spring Harbor Laboratory Meetings & Courses: Organizes prestigious biology-focused conferences and workshops with strong academic and industry attendance. Comparable as a long-running scientific meetings series in molecular biology and aging-related research.
• Ending Age-Related Diseases (Lifespan.io): Annual conference focused on rejuvenation biotechnology and age-related disease therapeutics. Most direct thematic competitor to ARDD in the longevity research conference space, though with a more advocacy-oriented positioning.

Broad incumbents

• Nature Conferences (Springer Nature): Publisher-affiliated conference series operated by Springer Nature covering a broad range of life sciences topics. Comparable as a scientific conference organizer with strong brand, academic credibility, and industry sponsorship.
• EBD Group / BioEurope: Organizer of major life sciences partnering conferences (BioEurope, BioEurope Spring). Comparable in format and industry sponsor base, though broader in therapeutic scope.

Emerging players

• Oxford Global Life Sciences Conferences: Organizer of multiple life sciences and drug discovery conferences with industry sponsorship. Comparable as a commercial conference organizer in the drug discovery space, though broader than ARDD's aging focus.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/@ardd3628/videos
• Xx.com/ARDD_meeting
• Facebookfacebook.com/agingpharma
• LinkedInlinkedin.com/company/agingpharma

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Aging Research and Drug Discovery